Clinical Trial Update: BMN 110 Phase 3B in Australian Patients [Phase 3]

View source ↗

Summary

Phase 3B trial update for BMN 110 in Australian patients with Morquio A syndrome (Mucopolysaccharidosis IVA) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morquio Syndrome
• Mucopolysaccharidosis Iva

Drugs mentioned

• BMN 110

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Mucopolysaccharidosis IVA (Morquio A Syndrome) | Phase 3 | Status: COMPLETED